Mar 09, 2021 / 06:15PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
All right. Here we go. Good afternoon, everybody. Luke Sergott from Barclays. I cover the life science tools and diagnostics space. And with me, I have the pleasure of introducing the Bio-Rad management team, Norman Schwartz, Ilan Daskal and Andy Last.
So if you guys want to give a quick kind of 2-minute update or a quick overview, that would be great, and then we can just dive right in.
Ilan Daskal - Bio-Rad Laboratories, Inc. - Executive VP & CFO
Sure, Luke. Probably you can dive in. I mean to your questions, we are obviously glad to participate in the Barclays conference. And let's start with the questions, and we can dive in.
Questions and Answers:
Luke England Sergott - Barclays Bank PLC, Research Division - Research AnalystThere we go. All right. So as you guys think about how your guidance, what you guys issued at the beginning of the year, and then we're already a full quarter in. Give us an update on how you